Bellentani S

Idioma: Ingles.
Referencias bibliográficas: 9
Paginas: 315-316
Archivo PDF: 63.16 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Shim JJ. Body iron, serum ferritin, and nonalcoholic fatty liver disease. Korean J Hepatol 2012; 18: 105-7.

2. Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 2009; 8(Suppl 1): S4-S8.

3. Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, Lonardo A. From NAFLD in clinical practice to answers from guidelines. J Hepatol 2013; 59: 859-71.

4. Fujita N, Takei Y. Iron overload in nonalcoholic steatohepatitis. Adv Clin Chem 2011; 55: 105-32.

5. Valenti L, Fracanzani AL, Dongiovanni P, Bugianesi E, Marchesini G, Manzini P, Vanni E, et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 2007; 102: 1251-8.

6. Yoneda M, Nozaki Y, Endo H, Mawatari H, Iida H, Fujita K, Yoneda K, et al. Serum ferritin is a clinical biomarker in Japanese patients withnonalcoholic steatohepatitis (NASH) independent of HFE gene mutation. Dig Dis Sci 2010; 55: 808-14.

7. Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, Motta BM, Bertelli C, et al. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2011; 21: 568-75.

8. Beaton MD, Chakrabarti S, Adams PC. Inflammation is not the cause o fan elevated serum ferritin in non-alcoholic fatty liver disease. Ann Hepatol 2014; 13: pp. 353-56.

9. Baptista-Gonzalez H, Chavez-Tapia NC, Zamora-Valdés D, Uribe M, Mendez-Sanchez N. Importance of iron and iron metabolism in nonalcoholic fatty liver disease. Mini Rev Med Chem 2008; 8: 171-4.